Skip to main content
SpringerLink
Log in

Factors affecting the extent of fetal fragility induced by histamine H1 antagonists

  • Published:
Inflammation Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Department of Life Sciences, University of East London, Romford Road, London E15 4LZ, UK, , , , , , GB

    G. Sturman, P. Freeman, H. M. Meade & N. A. Seeley

  2. Zeneca Pharmaceuticals Ltd., Alderley Park, Nr. Macclesfield, Cheshire SK10 4TG, UK, , , , , , GB

    W. J. Davies

Authors
  1. G. Sturman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Freeman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. M. Meade
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. A. Seeley
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. J. Davies
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sturman, G., Freeman, P., Meade, H. et al. Factors affecting the extent of fetal fragility induced by histamine H1 antagonists. Inflamm. res. 46 (Suppl 1), 53–54 (1997). https://doi.org/10.1007/s000110050065

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s000110050065

Keywords

Search

Navigation